摘要
Machine learning (ML)-augmented nanobiosensors have emerged as transformative platforms for rapid, sensitive, and real-time healthcare diagnostics. By integrating biological recognition elements with advanced transduction systems and data-driven analytical approaches, these intelligent biosensing platforms significantly enhance disease detection, biomarker analysis, and diagnosis. This review critically examines recent advances in electrochemical, optical, piezoelectric, and nanomaterial-based biosensors coupled with ML algorithms, including convolutional neural networks (CNNs), support vector machines (SVMs), random forests (RF), and artificial neural networks (ANNs). Emphasis is placed on the role of nanomaterials such as graphene, carbon nanotubes, quantum dots, MXenes, plasmonic nanoparticles, and other nanostructured interfaces in improving sensitivity, selectivity, and signal amplification. The review further highlights emerging applications in point-of-care diagnostics, wearable and implantable healthcare devices, chronic disease management, and early-stage cancer detection. Emerging trends including Internet of Things (IoT)-enabled biosensing, edge computing, multiplexed sensing, and personalized medicine are also explored as future directions for intelligent diagnostic technologies. Overall, this review provides a comprehensive and critical perspective on the convergence of ML and nanobiosensors for next-generation precision healthcare systems.